Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 15;18(2):e0269350. doi: 10.1371/journal.pone.0269350

Telemedicine and its acceptance by patients with type 2 diabetes mellitus at a single care center during the COVID-19 emergency: A cross-sectional observational study

Giovanni Sartore 1, Rosaria Caprino 1,*, Eugenio Ragazzi 2, Annunziata Lapolla 1
Editor: Pracheth Raghuveer3
PMCID: PMC9931089  PMID: 36791131

Abstract

Introduction

When Italy was placed under lockdown to contain the COVID-19 pandemic from 9 March to 18 May 2020, alternative approaches to delivering care—such as telemedicine—were promoted for patients with chronic diseases like diabetes mellitus (DM). The aim of this study was to analyze patients’ perception of, and satisfaction with the telehealth services offered during the COVID-19 emergency at an outpatient diabetes care unit in Italy.

Methods

A cross-sectional survey was conducted on 250 patients with type 2 diabetes mellitus who regularly attended our diabetes care unit. Data were collected by means of telephone interviews, asking patients how they perceived the telehealth services, and their satisfaction with the televisit and computer-based care. A standardized questionnaire was administered: there were questions answered using a five-point Likert scale, and one open-ended question. Patients’ demographic, anthropometric and biological data were collected from their medical records. Correlations between patients’ characteristics, their perception of telemedicine, and their satisfaction with the televisit were examined. Spearman’s rank-order correlation coefficient ρ (rho) and Kendall’s rank correlation coefficient τ (tau) were used as nonparametric measures of the strength of the association between the scores obtained for the two ordinal variables, Perception and Satisfaction, and between other clinical parameters. Principal component analysis (PCA) was also used to assess overall links between the variables.

Results

Almost half of the interviewees expressed a strongly positive perception of the medical services received, and more than 60% were very satisfied with the telehealth service provided during the COVID-19 emergency. There was a strong correlation between patients’ perception and satisfaction ratings (p<0.0001). Duration of disease showed a significant positive correlation with patients’ satisfaction with their medical care. By means of PCA, it was found that BMI correlated inversely with both perception and satisfaction. Following a qualitative analysis of patients’ answers to the open-ended question, contact with their specialist was important to them: it was reassuring and a source of scientifically correct information about their disease and the association between COVID-19 and diabetes.

Conclusions

Based on our telephone interviews, patients appreciated the telehealth approach and were satisfied with it, regardless of the characteristics of their disease. Telemedicine proved essential to avoid interrupting the continuity of care, and therefore had not only clinical, but also psycho-social repercussions.

Introduction

Diabetes mellitus (DM) has been defined as the second most common comorbidity in cases of COVID-19 [1], and research showed that diabetes negatively affects the prognosis in patients infected with COVID-19 [2,3]. Well-controlled blood glucose levels, maintaining glycemic variability within the range of 3.9 to 10.0 mmol/L, is associated with a significant reduction in the composite adverse outcomes and death [3]. On the other hand, poor glycemic control in patients with COVID-19 and pre-existing type 2 DM (T2DM) are associated with a worse outcome, a greater need for medical interventions, multi-organ injuries, and a higher mortality rate [4].

The COVID-19 pandemic did not only have an impact on people’s physical health, it also prompted psychological repercussions–given its huge coverage by the mass media. Every country’s citizens were experiencing anxiety, depression and stress–sometimes to such a degree that the psychological impact of lockdown was found to include post-traumatic stress, confusion and anger [5,6]. The strict emergency measures imposed to contain the virus suddenly upset people’s normal lifestyles, with consequences on their psychological wellbeing and emotional states.

With the support of their health team, patients with diabetes have to take some responsibility for their own health and self-manage their medication. They can experience depression, anxiety, loneliness, worries and fears, and are liable to eating disorders, diabetes-related distress, and other issues associated with managing a chronic condition. Individuals with T2DM are up to twice as likely to have such psychosocial problems as members of the general population [7,8].

Joensen et al. [9] found that patients with diabetes who reported moderate-to-high levels of distress were more frequently concerned about “being overly affected by COVID-19 diabetes”, or the fact that “people with diabetes are characterized as a risk group”. They worried about “not being able to manage [their] diabetes if infected with COVID-19”, about a “reduced quality of diabetes care” and “insufficient access to HCP (healthcare providers) if needed”. Those who felt isolated and starved of company were also more likely to worry. Patients who missed having someone to talk to about their diabetes and felt lonely were also more likely to be worried. Another study [10], which involved the use of telemedicine, investigated the impact of living alone on glycemia in the context of anxiety associated with the risk of becoming infected with COVID-19. Positive correlations were found for fasting glycemia, duration of diabetes, and postprandial glycemia in patients with high anxiety scores. Patients who were lonely emerged as a psychologically vulnerable population with poor glycemic outcomes. This study emphasized the importance of considering the influence of the COVID-19 pandemic and the overlap between glycemic and psychological aspects in a patient’s management. Patients with diabetes have specific concerns regarding COVID-19 and their chronic disease, and this negatively affects their psychosocial health. These concerns should be addressed by providing people with diabetes answers to their specific questions and needs, and frequent updates on what we know about COVID-19 and diabetes. For diabetics, having access to emotional support [11] may be even more important during a pandemic, and telemedicine can be part of the solution [12,13]: it can reduce the anxiety of patients with T2DM, and thereby improve their glycemic control. Telehealth has an important role too, primarily in limiting the risk of exposure to the virus for patients and doctors, but also as a method for delivering several healthcare services.

Barr and Podolsky [14] wrote that epidemics, like wars, have the potential to catalyze and reconfigure developments in medicine and public health. During the COVID-19 pandemic, Webster [15] recorded a ten-fold increase in the use of telemedicine within a matter of weeks. For healthcare providers, this means developing skills in building virtual relationships, empathy, diagnostics, and providing advice to ensure a good-quality service, and planning efficient and effective interventions that benefit their patients. Care delivery modalities like telemedicine had already been promoted for the management of chronic diseases, especially DM, and they had been favorably received by patients [16]. Now the COVID-19 pandemic has made research on patient satisfaction in this setting much more important [17]. Few data are available as yet regarding this topic in patients with T2DM, particularly under lockdown conditions.

Italy was first placed under lockdown to contain the COVID-19 pandemic from 9 March to 18 May 2020. The COVID-19 emergency represented a moment of profound reflection for many healthcare sectors, and diabetologists had to focus on how best to manage patients who could no longer attend diabetes care centers. The question was whether telemedicine could serve as an integrated care-providing solution that would be acceptable to T2DM patients and enable the diabetes-related problems they experienced to be managed.

Materials and methods

Study design and population

A cross-sectional survey was conducted to examine patients’ perception of, and satisfaction with the telemedicine service made available for telehealth consultations with the Public Diabetes Clinic of the ULSS 6 District Health Unit in Padua (north-east Italy) during a period of COVID-19 lockdown. The study was conducted in accordance with the Standards of Good Clinical Practice, as established by the Declaration of Helsinki. The study protocol was approved by the Ethics Committee for Clinical Trials in the Province of Padova, reference study No. 4964/U6/20. Verbal informed consent was given by all participants prior to their inclusion. All data were kept anonymized to protect participants’ identity.

The study population consisted of adult patients (over 18 years old) with a history of T2DM, who had a telemedicine consultation (total number of televisits = 2463) with a diabetologist during the Italian COVID-19 lockdown from March to May 2020. Telemedicine consultation consisted in a telephone call that replaced the check-up visit, where the reports sent by e-mail were analyzed and a therapy confirmed or set.

Sample size was determined based on previous cross-sectional studies on telemedicine, reporting a high degree of satisfaction [18,19]. With a provisional estimate of 80% of satisfied/very satisfied patients, a precision value of 0.05 and a Z-value of 1.96 (at 5% type I error), the formula [20] yielded a sample size of 246 subjects, that was rounded to 250.

Patients with the above characteristics were randomly selected and contacted, until reaching the scheduled sample size of 250. The number of patients selected was evenly distributed among the various diabetologists on the team to ensure that satisfaction with a given doctor was not a confounding factor.

The study was conducted between 21 July and 14 August 2020. Data were collected by means of a questionnaire during a telephone call made by a single operator, who took a neutral stance with the respondent. The operator stressed that the questionnaire was anonymous and explained that the purpose of the interview was for scientific research, not to assess the respondent’s doctor. Three questions were used to assess patients’ satisfaction: a Client Satisfaction Questionnaire (CSQ-3) was adapted for the purpose of discussing a telemedicine service, and also to promote the interviewees’ adherence, and ensure that they understood the questions. The CSQ has shown a good reliability and validity, and it has been applied to a variety of hospital services [2124]. Perception and satisfaction in the CSQ-3 was assessed using a five-point Likert scale [25].

Patients were asked about how they perceived the service: their attitude to it; how their expectations compared with the services received [26], and how they felt about telemedicine being used to manage DM. They were also asked about their satisfaction with the televisit, in terms of their emotions and individual experience of the healthcare provided during the telephone consultation. Each telephone interview lasted 15–20 minutes and was conducted in a room reserved at the outpatient clinic. Each variable considered in the questionnaire was scored from 1 to 5, where 1 meant a poor perception or satisfaction, and 5 meant a very strong perception or satisfaction. An open-ended question was then presented, asking respondents to provide feedback on the teleconsultation experience in their own words. Opinions on telemedicine were extracted and descriptively synthesized. They were divided into subgroups, then grouped into two broad categories, those in support and those against telemedicine.

Patients’ demographic, biological and anthropometric data, including gender, age, duration of diabetes, glycated hemoglobin (HbA1c), body mass index (BMI), serum creatinine, and eGFR, were obtained from their medical records and used for the statistical analysis of the cohort.

Data analysis

The data are presented as means ±SD, and as medians with interquartile ranges (IQR, calculated as the difference between 75th and 25th centiles). Spearman’s rank-order correlation coefficient ρ (rho), and Kendall’s rank correlation coefficient τ (tau) were used as nonparametric measures of the strength of the association between the scores obtained for the two ordinal variables, Perception and Satisfaction. Spearman’s rank-order correlation coefficient was also calculated to compare the scores versus the other variables available, such as the patients’ clinical and metabolic parameters. Statistical significance was assumed for p <0.05.

The principal component analysis (PCA), a multivariate method of data evaluation, was applied to the previously mentioned data to obtain an overall picture of any links between the variables. The resulting biplot graph shows the score plot and the loading plot for the first two principal components. For the loading plot, the angles between the vectors indicate the degree of correlation with one another. For vectors forming a closed angle, the variables they represent are positively correlated. Conversely, for divergent vectors characterized by open angles nearing 180°, the variables are negatively correlated; a 90° angle indicates no correlation between two variables.

Results

Patients’ perceptions and levels of satisfaction, and their correlation with other variables

During the Italian lockdown in the spring of 2020, there were 2,463 televisits conducted for patients with T2DM. From among these cases, 250 patients were enrolled in the study and interviewed (Fig 1).

Fig 1. STROBE diagram for various phases of the study.

Fig 1

Table 1 shows these patients’ main characteristics, and their perception and satisfaction scores.

Table 1. Characteristics of T2DM patients enrolled in the study (n = 250; male/female: 60%/40%).

Variable mean ± SD median (IQR)
Age, y 70.1±11.0 71 (16)
Duration of diabetes, y 14.2±9.6 13 (14)
HbA1c, % 7.4±1.1 7.3 (1.3)
BMI, kg/m2 29.5±4.8 29.1 (6.5)
Serum creatinine, mg/dL 0.99±0.34 0.90 (0.40)
eGFR, mL/min ·1.73m2 80.0±25.1 81.0 (37.0)
Perception of televisit
(score 1 to 5)
4.0±1.2 4 (2)
Satisfaction with televisit
(score 1 to 5)
4.4±0.9 5 (1)

IQR: Interquartile range, calculated as the difference between the 75th and 25th centiles.

Fig 2A shows how patients perceived their televisit. Nearly half the cohort (49.0%) awarded it a maximum score of 5, and for another 23.0% it scored 4 out of 5. In general, the higher the score from 1 to 5 (on a scale of increasing satisfaction from “not at all positive” to “very positive”), the higher the proportion of patients awarding it for their perception of the televisit.

Fig 2.

Fig 2

Distribution of the scores expressed by patients regarding their “Perception” of (A) and “Satisfaction” with (B) the telemedicine service. Scores were given on a five-point scale, from 1 (very low) to 5 (very high). The percentage of the sample is given above each bar.

Fig 2B shows that patient satisfaction was also generally high, when referring to the doctor’s performance: 24.0% of the sample reported being satisfied (score 4) and 64.0% were very satisfied (score 5).

Fig 3 shows the strong correlation between the perception and satisfaction parameters (p<0.0001). Spearman’s rank-order correlation coefficient ρ (rho) was used as a nonparametric measure of the strength of the association between the two variables. Kendall’s rank correlation coefficient τ (tau) was calculated to confirm the ordinal association between the variables. Both coefficients were statistically significant (p<0.0001).

Fig 3. Correlation between “Perception” and “Satisfaction”.

Fig 3

Spearman’s rank-order correlation coefficient ρ (rho) was used as a nonparametric measure of the strength of the association between the two variables. Kendall’s rank correlation coefficient τ (tau) was calculated to confirm the ordinal association between the variables. Both coefficients were statistically significant (p<0.0001).

Table 2 shows the results regarding possible correlations between perception or satisfaction and age, HbA1c, BMI and duration of diabetes. The only significant correlation was between patients’ satisfaction and the duration of their disease (p = 0.0247).

Table 2. Correlation between scores (1 to 5) obtained for “Perception” and “Satisfaction” versus the variables considered.

1st variable    vs    2nd variable Spearman’s rho p
Perception Age, y -0.0531 0.4035
Duration of diabetes, y 0.0854 0.1781
HbA1c, % 0.0325 0.6325
BMI, kg/m2 -0.0527 0.4357
Serum creatinine, mg/dL -0.0402 0.5571
eGFR, mL/min ·1.73m2 0.0417 0.5430
Satisfaction Age, y -0.0196 0.7574
Duration of diabetes, y 0.1420 0.0247 *
HbA1c, % 0.0462 0.4966
BMI, kg/m2 -0.0523 0.4394
Serum creatinine, mg/dL 0.0577 0.3985
eGFR, mL/min ·1.73m2 -0.0565 0.4098

(*) Statistically significant value.

A further analysis of data was obtained by means of PCA, a multivariate method that gives a general overview of underlying correlations that exist in a set of variables. When PCA was applied to the previously considered parameters, an inversely proportional correlation emerged between eGFR and HbA1c, and between eGFR and age (see the biplot graph in Fig 4). A partial correlation was found for both perception and satisfaction in relation to duration of disease, confirming the above-mentioned nonparametric finding. PCA also confirmed the close association between patients’ perception of, and satisfaction with the televisit, which both appeared to be correlated inversely with their BMI.

Fig 4. Biplot of the first two components (on correlations) in the principal component analysis.

Fig 4

The Perception and Satisfaction variables were closely related, and the correlated moderately with the duration of diabetes, and inversely with BMI. According to this non-parametric analysis, there were no other correlations between the scores for Perception or Satisfaction and the other variables. Red dots indicate female patients, and blue dots indicate male patients; there were no distinctive clusters by sex.

Patients’ opinions

During the telephone interviews, patients were asked what they thought about their televisit experience. The points raised against telemedicine were a lack of direct face-to-face contact with the physician, and organizational problems (when booking another visit, for instance). The strengths patients identified were much more numerous. They were particularly grateful that the diabetes care service was not interrupted by the pandemic. They were relieved that they could still talk to their diabetologist, and access scientifically reliable information about the correlation between diabetes and COVID-19. Even patients unwilling to go to a hospital or clinics for fear of the infection were still able to have a doctor’s appointment. Patients often described the televisit as being as good as a face-to-face visit. Other considerations concerned the benefits of saving time, not having to queue, and not having to look for a car parking space.

Discussion

The use of telehealth services to support and promote long-distance clinical care, education, and health management plays a key role in disaster response [27]. In several ways, the COVID-19 pandemic could be compared with a hurricane (particularly during lockdowns), and its impact could be particularly significant and persistent on healthcare delivery for patients with chronic diseases.

In our experience, using telemedicine to connect physicians and patients with T2DM via emails, phone calls, and text messages on mobile phones enabled patients to receive appropriate medical care. This approach was very positively perceived by our diabetic patients, whose satisfaction–regardless of their clinical features—confirmed recent findings concerning other chronic diseases [19,28,29].

An exception, highlighted thanks to the multivariate technique of PCA, was the inverse correlation emerging between patients’ perception and satisfaction and their BMI. In other studies [3032], obese people were reportedly less satisfied because they felt they had benefited less from their telemedical appointments than from face-to-face visits. This was probably because their therapy was closely linked to their lifestyle. Under lockdown conditions, the psychological stress of home confinement might also have triggered the onset or re-emergence of problematic eating patterns that, combined with a more limited physical exercise, would have resulted in unwanted weight gains [28]. Social distancing and lockdowns have influenced the general population’s eating habits and physical activity levels too, but obese patients are those who have suffered the most [31]. A study by Athanasiadis et al. examined 208 patients who had previously undergone bariatric surgery, and they had all gained weight during the COVID-19 pandemic [32]. Apart from the decrease in physical activity, other risk factors for weight gain during lockdown were a lower consumption of healthy foods, loss of control when eating, and an increase in binge eating and snacking [32]. Social distancing also reportedly reduces the fear of confronting and of being judged negatively by others [33]. In fact, living with a larger number of people was found to reduce the risk of maladaptive eating due to emotional distress [34]. In short, our obese diabetic patients may have been less satisfied with their televisit because face-to-face visits normally brought benefits not only by providing drug therapies, but also by prompting changes in lifestyle, which is something that telemedicine could not do during lockdown. Being diabetic in times of COVID-19 raises the risk of hospitalization by three times, but for people who are diabetic and obese the risk is 4.5 times higher. Diabetes and obesity are also often associated with other cardiovascular risk factors, so patients therefore require a comprehensive approach [35] that was not available to them during the first lockdown. It may be that future improvements to the quality of care via telemedicine will enable healthcare providers to develop tailored interventions to better support these patients.

It is worth noting the close correlation that emerged between patients’ satisfaction with their televisits and the duration of their diabetes. Previous studies had also found a significant correlation between diabetic patients’ satisfaction with their treatment and the duration of their disease. It may be that patients with more experience, higher self-efficacy, and a greater knowledge of self-management strategies would benefit more from telemedicine services, and this could be taken into account in the management of diabetes in future. Duration of disease may also relate to patients’ acceptance of their chronic condition, as they learn to cope with it better. Accepting a chronic disease takes time, and diabetic patients have to understand the importance of self-care and self-management [36]. Patients get to know their therapeutic and behavioral needs, which include proper nutrition and physical exercise, but they also need the diabetologist’s periodic reinforcement. Diabetes self-management is a continuous learning process, which also benefits patients’ psychosocial aspects and emotional well-being.

In general, our sample’s satisfaction could be justified because their televisits enabled their disease to be managed, stimulating their adherence to therapies, routine blood glucose monitoring, healthy eating habits, and exercise. The influence of an effective doctor-patient relationship in promoting emotional well-being and treatment adherence is well established [37,38], and the quality of the doctor-patient relationship has been shown to predict a range of health outcomes in people with diabetes [39]. A patient-centered relationship is associated with better diabetes self-care, greater adherence to treatment and psychosocial outcomes, and lower levels of stress because it nurtures patients’ perceptions of their ability to self-manage their condition. An effective doctor-patient relationship relies on good communications from the doctor, and the patients’ involvement in decision-making processes regarding their treatment, making sure they understand the benefits and importance of therapy [40]. Our open-ended questions clearly demonstrated the strong impact of the doctor-patient relationship when patients assessed their satisfaction with their televisit. Most of them seemed satisfied with the service (regardless of their glycemic control), and the empathic exchange they had with their doctor, even via remote means. This would suggest that telemedicine can have an intrinsic value, whatever the disease involved, that stems from the doctor-patient relationship, which concerns not only the clinical care aspect of a medical visit, but also the patient’s bio-psycho-social sphere.

Positive patients’ perception of telemedicine observed in this study was in agreement with previous ones carried out both in pre-COVID-19 and during COVID-19 era [4146]. Post-pandemic tele-consultation lessons strengthen its effective role, in particular in underserved and remote areas [47], but its potential has not been completely explored, especially from patients’ perspective [48]. On the one hand, there is a need of establishing telemedicine guidelines, training of consultants and advancement in technology [46], on the other hand of preventing the overuse in normal setting.

The present survey has some limitations. The size of the study sample is limited by its single-centered nature, as well as by considering T2DM patients and by the number of patients interviewed. Lack of information such as the educational status and current occupation would indicate how tech savvy the patients would have been to participate in tele-health consultations. Moreover, the study was conducted during severe restrictions period, which could be a partial confounding factor.

The present study confirms the importance of assessing patients’ perceptions of telemedicine in order to lay the foundations for its future development, ensuring that recent lockdown experiences serve as an opportunity to improve our understanding of clinical and practical issues for use in a post-COVID-19 future.

Acknowledgments

The authors thank the Staff of the outpatients’ clinics at the Diabetes Clinic of the ULSS 6 District Health Unit in Padua for their cooperation, in particular Silvia Barbieri, Giuseppe Bax, Stefano Bassan, Lara Benetollo, Barbara Bonsembiante, Antonella Bortoletto, Federica Capovilla, Maria Grazia Dalfrà, Luisa Delorenzi, Lara Fanicchi, Alessandra Gallo, Debora Maggiolo, Michela Masin, Silvia Minardi, Beatrice Moro, Gloria Muraro, Isabella Negro, Manuela Nogara, Silvia Pastrolin, Roberta Penello, Francesco Piarulli, Susanna Picci, Mirella Pinton, Carlo Tintori, Barbara Toninello and Debora Vianello, and all the patients who agreed to take part in the investigation.

Data Availability

Data are available from Zenodo (DOI: 10.5281/zenodo.7010557).

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Zhou F. et al. , “Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study,” Lancet, vol. 395, no. 10229, 2020, doi: 10.1016/S0140-6736(20)30566-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hu L. et al. , “Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China,” Clinical Infectious Diseases, 2020, doi: 10.1093/cid/ciaa539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zhu L. et al. , “Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes,” Cell Metabolism, vol. 31, no. 6, 2020, doi: 10.1016/j.cmet.2020.04.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bornstein S. R. et al. , “Practical recommendations for the management of diabetes in patients with COVID-19,” The Lancet Diabetes and Endocrinology, vol. 8, no. 6. 2020, doi: 10.1016/S2213-8587(20)30152-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Garfin D. R. et al. , “The novel coronavirus (COVID-2019) outbreak: Amplification of public health consequences by media exposure,” Health Psychology, vol. 39, no. 5. 2020, doi: 10.1037/hea0000875 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Brooks S. K. et al. , “The psychological impact of quarantine and how to reduce it: rapid review of the evidence,” The Lancet, vol. 395, no. 10227. 2020, doi: 10.1016/S0140-6736(20)30460-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Young-Hyman D. et al. , “Psychosocial care for people with diabetes: A position statement of the American diabetes association,” Diabetes Care, vol. 39, no. 12. 2016, doi: 10.2337/dc16-2053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bădescu S. V. et al. , “The association between Diabetes mellitus and Depression,” Journal of medicine and life, vol. 9, no. 2. 2016. [PMC free article] [PubMed] [Google Scholar]
  • 9.Joensen L. E. et al. , “Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark—what characterizes people with high levels of COVID-19-related worries?,” Diabetic Medicine, vol. 37, no. 7, 2020, doi: 10.1111/dme.14319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fatyga E. et al. , “The coronavirus disease 2019 pandemic: Telemedicine in elderly patients with type 2 diabetes,” Polish Archives of Internal Medicine, vol. 130, no. 5. 2020, doi: 10.20452/pamw.15346 [DOI] [PubMed] [Google Scholar]
  • 11.Jones A. et al. , “If it does not significantly change HbA1c levels why should we waste time on it? A plea for the prioritization of psychological well-being in people with diabetes,” Diabetic Medicine, vol. 32, no. 2. 2015, doi: 10.1111/dme.12620 [DOI] [PubMed] [Google Scholar]
  • 12.Joensen L. E. et al. , “Patient perspectives on peer support for adults with type 1 diabetes: A need for diabetes-specific social capital,” Patient Preference and Adherence, vol. 10, 2016, doi: 10.2147/PPA.S111696 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kingod N., “The tinkering m-patient: Co-constructing knowledge on how to live with type 1 diabetes through Facebook searching and sharing and offline tinkering with self-care,” Health (United Kingdom), vol. 24, no. 2, 2020, doi: 10.1177/1363459318800140 [DOI] [PubMed] [Google Scholar]
  • 14.Barr J. and Podolsky S. H., “A National Medical Response to Crisis—The Legacy of World War II,” N. England Journal Medicine, 2020, doi: 10.1056/NEJMp2008512 [DOI] [PubMed] [Google Scholar]
  • 15.Webster P., “Virtual health care in the era of COVID-19,” Lancet (London, England). 2020, doi: 10.1016/S0140-6736(20)30818-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Dario C. et al. , “Assessment of patients’ perception of telemedicine services using the service user technology acceptability questionnaire,” International Journal of Integrated Care, vol. 16, no. 2, 2016, doi: 10.5334/ijic.2219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hawrysz L. et al. , “The research on patient satisfaction with remote healthcare prior to and during the covid-19 pandemic,” International Journal of Environmental Research and Public Health, 2021, doi: 10.3390/ijerph18105338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Palandri F. et al. , “How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey,” Leukemia. 2020, doi: 10.1038/s41375-020-0953-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Riley P. E. et al. , “Patient and Provider Satisfaction With Telemedicine in Otolaryngology,” OTO Open, 2021, doi: 10.1177/2473974X20981838 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wang X. and Ji X., “Sample Size Estimation in Clinical Research: From Randomized Controlled Trials to Observational Studies,” Chest Journal 2020, doi: 10.1016/j.chest.2020.03.010 [DOI] [PubMed] [Google Scholar]
  • 21.Attkisson C. C. and Greenfield T. K., “Client Satisfaction Questionnaire-8 and Service Satisfaction Scale-30,” in The Use of Psychological Testing for Treatment Planning and Outcome Assessment, 1994. [Google Scholar]
  • 22.Christensen L. F. et al. , “Disagreement in satisfaction between patients and providers in the use of videoconferences by depressed adults,” Telemedicine and e-Health, 2020, doi: 10.1089/tmj.2019.0055 [DOI] [PubMed] [Google Scholar]
  • 23.Mol M. et al. , “Dimensionality of the system usability scale among professionals using internet-based interventions for depression: A confirmatory factor analysis,” BMC Psychiatry, 2020, doi: 10.1186/s12888-020-02627-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hajesmaeel-Gohari S. and Bahaadinbeigy K., “The most used questionnaires for evaluating telemedicine services,” BMC Medical Informatics and Decision Making, 2021, doi: 10.1186/s12911-021-01407-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sullivan G. M. and Artino A. R., “Analyzing and Interpreting Data From Likert-Type Scales,” Journal of Graduate Medical Education, 2013, doi: 10.4300/JGME-5-4-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.a Parasuraman, et al. , “SERQUAL: A Multiple-Item scale for Measuring Consumer Perceptions of Service Quality,” Journal of Retailing. 1988, doi: 10.1016/S0148-2963(99)00084-3 [DOI] [Google Scholar]
  • 27.Lurie N. and Carr B. G., “The role of telehealth in the medical response to disasters,” JAMA Internal Medicine, vol. 178, no. 6. 2018, doi: 10.1001/jamainternmed.2018.1314 [DOI] [PubMed] [Google Scholar]
  • 28.Kupfer J. M. and Bond E. U., “Patient satisfaction and patient-centered care: Necessary but not equal,” JAMA—Journal of the American Medical Association, vol. 308, no. 2. 2012, doi: 10.1001/jama.2012.7381 [DOI] [PubMed] [Google Scholar]
  • 29.Palandri F. et al. , “Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction,” British Journal of Haematology. 2021, doi: 10.1111/bjh.17208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Weissman R. S. et al. , “Access to evidence-based care for eating disorders during the COVID-19 crisis,” International Journal of Eating Disorders. 2020, doi: 10.1002/eat.23279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Walędziak M. et al. , “Influence of covid-19 pandemic lockdown on patients from the bariatric surgery waiting list,” Medicina (Kaunas), 2021, doi: 10.3390/medicina57050505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Athanasiadis D. I. et al. , “How are bariatric patients coping during the coronavirus disease 2019 (COVID-19) pandemic? Analysis of factors known to cause weight regain among postoperative bariatric patients,” Surgery of Obesity and Related Diseases, 2021, doi: 10.1016/j.soard.2020.11.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Albert U. et al. , “Effect of SARS-CoV-2 (COVID-19) Pandemic and Lockdown on Body Weight, Maladaptive Eating Habits, Anxiety, and Depression in a Bariatric Surgery Waiting List Cohort,” Obesity Surgery, 2021, doi: 10.1007/s11695-021-05257-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Félix S. et al. , “A preliminary study on the psychosocial impact of COVID-19 lockdown in post-bariatric surgery women: the importance of eating behavior, health care access, and social support,” Current Psychology, 2021, doi: 10.1007/s12144-021-01529-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Centers for Disease Control and Prevention., “Assessing risk factors for severe COVID-19 illness.,” https://www.cdc.gov/coronavirus/2019-ncov/covid-data/ Investig., 2020. [PubMed] [Google Scholar]
  • 36.Da Silva J. A. et al. , “Diagnosis of diabetes mellitus and living with a chronic condition: Participatory study,” BMC Public Health, vol. 18, no. 1, 2018, doi: 10.1186/s12889-018-5637-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ha J. F. and Longnecker N., “Doctor-patient communication: A review,” Ochsner Journal. 2010, doi: 10.3329/jbcps.v32i2.26036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Stewart M. A., “Effective physician-patient communication and health outcomes: A review,” Canadian Medical Association Journal, 1995. [PMC free article] [PubMed] [Google Scholar]
  • 39.Giorgino F. et al. , “Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa,” Diabetes Research and Clinical Practice. 2021, doi: 10.1016/j.diabres.2020.108617 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bridges H. A. and Smith M. A., “Mediation by illness perceptions of the association between the doctor-patient relationship and diabetes-related distress,” Journal of Health Psychology, 2016, doi: 10.1177/1359105315569094 [DOI] [PubMed] [Google Scholar]
  • 41.Marta Bassi M. M. et al. , “Patient Satisfaction of Telemedicine in Pediatric and Young Adult Type 1 Diabetes Patients During Covid-19 Pandemic,” Front Public Health. doi: 10.3389/fpubh.2022.857561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bizot A. et al. , “Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic,” British Journal Cancer, 2021, doi: 10.1038/s41416-021-01555-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Aashima A. et al. , “A Review of Patient Satisfaction and Experience with Telemedicine: A Virtual Solution during and beyond COVID-19 Pandemic,” Telemedicine and e-Health. 2021, doi: 10.1089/tmj.2020.0570 [DOI] [PubMed] [Google Scholar]
  • 44.Nguyen M. et al. , “A Review of Patient and Provider Satisfaction with Telemedicine,” Current Allergy and Asthma Reports. 2020, doi: 10.1007/s11882-020-00969-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sahin E. et al. , “Perceptions and acceptance of telemedicine among medical oncologists before and during the COVID-19 pandemic in Turkey,” Supportive Care in Cancer, 2021, doi: 10.1007/s00520-021-06290-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Khan Z. A. et al. , “Evaluation of Patient Perception and Satisfaction Toward the Use of Telemedicine during Pandemic of Novel Coronavirus in Pakistan,” Telemedine and e-Health, 2021, doi: 10.1089/tmj.2020.0343 [DOI] [PubMed] [Google Scholar]
  • 47.Orlando J. F. et al. , “Systematic review of patient and caregivers’ satisfaction with telehealth videoconferencing as a mode of service delivery in managing patients’ health,” PLoS One, 2019, doi: 10.1371/journal.pone.0221848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Pappot N. et al. , “Telemedicine and e-Health Solutions for COVID-19: Patients’ Perspective,” Telemedicine and e-Health. 2020, doi: 10.1089/tmj.2020.0099 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Pracheth Raghuveer

28 Jun 2022

PONE-D-22-14329Telemedicine and its acceptance by patients with type 2 diabetes mellitus at a single care center during the COVID-19 emergency: A prospective observational studyPLOS ONE

Dear Dr. Rosaria Caprino

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 12th August, 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Pracheth Raghuveer, MD, DNB

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Additional Editor Comments: STROBE diagram needs to be added. There are many grammatical errors that need correction. The discussion needs improvement. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. sample size could have been increased for better inference.

2. few grammatical mistakes are there , please correct it.

3. please clarify , wether during telemedicine patient can see (Video interaction) their physician or not.

Reviewer #2: 1. This is a single cohort study without a control group during the Covid-19 pandemic when in person services were interrupted due to restrictions.

2. While methodology is sound the paper needs to be viewed in perspective.

3. This being a simple observational study it is not understood in what way “Standards of Good Clinical Practice and ICH Harmonized Tripartite Guidelines” were applicable in this study. These guidelines are for clinical trials.

4. Some care is better than no care. People around the world were numbed during the unprecedented severe restrictions in this period.

5. In such an environment even tele-consultation would have been welcome. The study findings need to be interpreted against this background.

6. Perhaps another study using same methods but in a post-pandemic setting would complement this study. Can be a recommendation in this paper.

7. Post pandemic tele-consultation lessons learned could be useful for delivering medical care in underserved and remote areas. However, the temptation to overuse it in normal settings should be checked.

8. May consider discussing some of these issues in the paper.

Reviewer #3: Dear author,

Thank you for undertaking this research to analyse the perceptions of patients on telehealth.

Overall the article is reasonably well presented. However I suggest that the following issues be addressed.

1. The setting needs to be well explained. The nature of the clinical practice (teaching or non teaching clinic), the characteristics of patients that are captured in this clinical practice whether it is a public or a private practice and the population that the clinic covers.

2. A STROBE diagram seems essential. Ideally it could start from the number of patients that attended the clinic during the study period number of type 2 diabetics, number who underwent tele health consultations and the number of patients who took part in the study. It is interesting that all 250 consecutive participants consented for the study and participated without any issues.

3. Sample size calculation has not been addressed. Starting from the hypothesis of this study, the reason as to how the number 250 was arrived at needs to be described clearly.

4. Regarding the study design, I disagree if this is a cohort study. There is no follow-up of patients. It seems to be a cross sectional study looking at the perspectives of type 2 diabetics who have attended tele-health consultation

5. While collecting baseline characteristics, a few other details could have been added. For example the sex distribution of the participants. Also the educational status, current occupation would indicate how tech savvy the patients would have been to participate in tele-health consultations.

6. The fact that this is a mixed method study with a qualitative component (the last open ended question of the questionnaire) the responses are ideally described as themes, sub themes and specific quotes. Also in the methodology section, there is paucity of information as to how this qualitative data was analysed.

7. The manuscript lacks a limitations section- even the best of studies will have its own limitations. It needs to be acknowledged.

8. In the discussion section, the generisability of the results need to be discussed. If similar results are expected in other parts of Italy or around the world.

9. Is there any specific reason why only type 2 diabetics were chosen and not any other types of diabetics?

10. The discussion seems to be more focused on BMI and the perception. But it is to be emphasised that there was a lack of statistical significance between the two, though there seemed to be a similar trend.

In summary, the above issues need to be addressed before considering this manuscript for publication.

Thank you for giving me the opportunity to review this manuscript.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Divendu Bhushan

Reviewer #2: Yes: Professor Amitav Banerjee, MD

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Feb 15;18(2):e0269350. doi: 10.1371/journal.pone.0269350.r002

Author response to Decision Letter 0


19 Aug 2022

We thank the Editor and the Reviewers for careful evaluation of our study and for all their valuable suggestions in order to improve the scientific merit of the manuscript. Detailed answers to all the criticisms are reported in the document.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Pracheth Raghuveer

16 Nov 2022

PONE-D-22-14329R1Telemedicine and its acceptance by patients with type 2 diabetes mellitus at a single care center during the COVID-19 emergency: A prospective observational studyPLOS ONE

Dear Dr. Caprino,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 31 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Pracheth Raghuveer, MD, DNB

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #3: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: Dear authors,

Thank you for addressing the queries / suggestions. I suggest that the following be clarified in the manuscript.

1. Being a cross-sectional study, the words "prospective" and "consecutive" can be removed. They are usually used in the context of a prospective cohort study. From your methodology section, it appears that you have chosen all 254 patients who attended the practice within the given time period.

2. In the STROBE diagram, there have been 2463 patients between March and May 2020, however only 254 between July and August 2020. Is there a reason why the numbers dramatically reduced?

3. As raised by one of the other reviewers, whether Telehealth consultation refers to a video call/consultation or just an audio telephonic call with email communication needs to be clarified better.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Feb 15;18(2):e0269350. doi: 10.1371/journal.pone.0269350.r004

Author response to Decision Letter 1


22 Nov 2022

Reviewer #3: Dear authors,

Thank you for addressing the queries / suggestions. I suggest that the following be clarified in the manuscript.

1. Being a cross-sectional study, the words "prospective" and "consecutive" can be removed. They are usually used in the context of a prospective cohort study. From your methodology section, it appears that you have chosen all 254 patients who attended the practice within the given time period.

We thank the Reviewer for suggestion. We deleted the words not appropriate for the study, and changed also STROBE diagram in order to make clearer the design of the survey.

2. In the STROBE diagram, there have been 2463 patients between March and May 2020, however only 254 between July and August 2020. Is there a reason why the numbers dramatically reduced?

The STROBE diagram was made clearer; the total number of televisits in the time intervals March - May 2020, corresponding to lockdown period, were 2463; among patients attending televisits, the survey recruited 250 patients who agreed to respond to the questionnaire.

3. As raised by one of the other reviewers, whether Telehealth consultation refers to a video call/consultation or just an audio telephonic call with email communication needs to be clarified better.

Telehealth consultation consisted of a telephone call. The information was explained better in the text.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Pracheth Raghuveer

2 Feb 2023

Telemedicine and its acceptance by patients with type 2 diabetes mellitus at a single care center during the COVID-19 emergency: A cross-sectional observational study

PONE-D-22-14329R2

Dear Dr. Caprino,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Pracheth Raghuveer, MD, DNB

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Author has responded to all points raised last time and did required modifications. This manuscript is technically sound and data given support the conclusion. Although author mentioned the difficulties , these can be better summarized as barrier to the tele medicine method of consultation. Statistical analysis appear good to me, but expert opinion can be taken.

Reviewer #3: Thank you for addressing my queries and suggestions. I am happy to accept the manuscript with the existing corrections.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: This article showed benefits and barriers of telemedicine consultations. During COVID era, it was used as a great tool to serve people. For looking satisfaction and more details of barriers , qualitative studies can be done. Divendu Bhushan

Reviewer #3: Yes: Vignesh Kumar Chandiraseharan

**********

Acceptance letter

Pracheth Raghuveer

7 Feb 2023

PONE-D-22-14329R2

Telemedicine and its acceptance by patients with type 2 diabetes mellitus at a single care center during the COVID-19 emergency: A cross-sectional observational study

Dear Dr. Caprino:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Pracheth Raghuveer

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    Data are available from Zenodo (DOI: 10.5281/zenodo.7010557).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES